Quick Links

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.


PER Pulse™ Recaps
The 1st Annual School of Gastrointestinal Oncology™ (SOGO™), which was held April 23, 2016, presented the latest data on the multidisciplinary management of patients with gastrointestinal cancers, including colorectal cancer (CRC), gastric cancer, pancreatic cancer, hepatocellular carcinoma, and others.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Celgene, Lilly, Sirtex, and Taiho Oncology, Inc.

For further information concerning Lilly grant funding, visit

Community Practice Connections™: 1st Annual School of Gastrointestinal Oncology™

Release Date: June 22, 2016
Expiration Date: June 22, 2017
Media: Internet - based

Activity Overview

Community Practice Connections: 1st Annual School of Gastrointestinal Oncology™ consists of a series of brief interviews with noted thought leaders exploring questions from the community physician perspective. The video interviews address decision points in the clinical vignettes, as well as questions commonly faced in the community oncology practice setting.

CME/CE Activity Table of Contents

  • Recent Updates in Treating Hepatocellular Carcinoma
    Ghassan K. Abou-Alfa, MD
  • Chemoprevention for GI Cancers
    Ghassan K. Abou-Alfa, MD
  • Multidisciplinary Management of Liver Metastases
    Michael A. Choti, MD, MBA, FACS
  • Update on the Management of Locoregional Gastric Cancer
    Michael A. Choti, MD, MBA, FACS
  • Future Therapies for the Management of Pancreas Cancer
    Michael A. Choti, MD, MBA, FACS
  • Hot Topics in GI Cancers
    John Marshall, MD

Instructions For This Activity & Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, "educational content/video" will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational activity is directed toward oncologists, as well as surgeons, pathologists, nurses, and fellows involved in the treatment and management of patients with gastrointestinal (GI) cancers. Physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of GI malignancies may also participate.

Educational Objectives

At the conclusion of this activity, you should be better prepared to:
  • Describe current and evolving patient and tumor information that can be used to stratify risk and inform clinical decision making in the management of gastrointestinal malignancies
  • Assess landmark clinical trial findings, and apply them to changing clinical practice paradigms to personalize care and optimize outcomes
  • Delineate effective strategies to proactively mitigate and manage predictable side effects related to the management of gastrointestinal malignancies to maximize treatment outcomes
  • Discuss emerging clinical trial findings on novel compounds and strategies to manage gastrointestinal malignancies
  • Apply emerging clinical trial data to manage cases in the context of evolving treatment paradigms for gastrointestinal tumors

Faculty, Staff, and Planners' Disclosures


Ghassan K. Abou-Alfa, MD
Medical Oncologist
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
New York, NY


Michael A Choti, MD, MBA, FACS
Professor and Chair
Department of Surgery
UT Southwestern Medical Center
Dallas, TX


John Marshall, MD
Chief, Division of Hematology/Oncology
Georgetown University Hospital
Director, Ruesch Center for the Cure of GI Cancers
Washington, DC

The following individuals have no relevant financial relationships with commercial interests:

The staff of Physicians’ Education Resource®, LLC
Michael A. Choti, MD, MBA, FACS

The following individuals have relevant financial relationships with commercial interests to disclose:

Ghassan K. Abou-Alfa, MD: Grant/Research Support -- Abbott Laboratories, Amgen, Bayer, Celgene, Eli Lilly and Company/ImClone, Exelixis, Genentech, Immunomedics, Incyte, Momenta Pharmaceuticals, Myriad Genetics, Novartis, OncoMed Pharmaceuticals, Polaris Pharmaceuticals, Roche, Vicus Therapeutics; Consultant -- Aduro Biotech, Array BioPharma, Astellas Pharma US, BioAlliance, Boston Scientifc, Boston Therapeutics, Bristol-Myers Squibb, CASI Pharmaceuticals, Celgene, Cipla, Eli Lilly and Company, Gilead Sciences, IntegraGen, MedImmune, Merrimack, Momenta, Novartis, Onxeo, Pharmacyclics, sanofi-aventis, Silenseed, SillaJen, Vicus Therapeutics; John Marshall, MD: Grant/Research Support -- Genentech, Amgen, Bayer, Celgene; Consultant -- Genentech, Amgen, Celgene, Bayer, Indivumed, Caris; Speakers Bureau -- Genentech, Amgen, Bayer, Celgene

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of Physicians' Education Resource®, LLC, (PER®) to ensure fair balance, independence, objectivity, and scientific rigor in all of our CME/CE activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as a part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical education purposes only, and is not meant to substitute for the independent medical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of Physicians' Education Resource®, LLC, or any of the companies that provided commercial support for this activity.

Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Become a Member

Forgot Password?
Calendar of Events
Filter By